Definition of treatment goals for moderate to severe psoriasis: a European consensusUlrich Mrowietz, Nikhil Yawalkar, M. Lahfa et al.|Archives of Dermatological Research|2010Cited by 892
European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatologyAlexander Enk, Detlef Zillikens, Eva Hadaschik et al.|Journal of the European Academy of Dermatology and Venereology|2016Cited by 65
Developing classification criteria for skin‐predominant dermatomyositis: the Delphi processJosef Symon S. Concha, Yoshinao Muro, S.M. Peña et al.|British Journal of Dermatology|2019Cited by 38
European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatologyAlexander Enk, Detlef Zillikens, Eva Hadaschik et al.|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2016Cited by 23
Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemiaElisabeth Reiter, Peter Kalhs, Hildegard Greinix et al.|Annals of Hematology|1999Cited by 21